Clinical Trial: Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy

U.S., Nov. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07226765) titled 'Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy' on Nov. 06.

Brief Summary: This Phase 3 clinical trial is designed to evaluate the efficacy and safety of maridebart cafraglutide compared to placebo over a 52-week period in adults with obstructive sleep apnea (OSA) who are not on PAP therapy and are living with overweight or obesity.

Study Start Date: Dec. 17

Study Type: INTERVENTIONAL

Condition: Obstructive Sleep Apnea

Intervention: DRUG: Maridebart cafraglutide

Participants will receive maridebart cafraglutide SC.

DRUG: Placebo

Partici...